Zrs Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Zrs Pharmaceuticals India
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rachna Bansal, Meenakshi Gupta, Harish Yadav, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304DL2021PTC386179
- Company No.
386179
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Zrs Pharmaceuticals India Private Limited offer?
Zrs Pharmaceuticals India Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antiepileptic Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Cardiovascular Drugs & Medication, Kidney Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Dietary Supplements, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Zrs Pharmaceuticals India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meenakshi Gupta  | Director | 06-Sep-2021 | Current |
| Harish Yadav | Director | 06-Sep-2021 | Current |
| Rachna Bansal | Director | 06-Sep-2021 | Current |
| Sohan Poonia | Director | 06-Sep-2021 | Current |
Financial Performance of Zrs Pharmaceuticals India.
Zrs Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Zrs Pharmaceuticals India?
Unlock access to Zrs Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zrs Pharmaceuticals India?
Unlock and access historical data on people associated with Zrs Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zrs Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zrs Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.